Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19

OBJECTIVES: COVID-19 is a public health emergency of international concern whose detection in recovered asymptomatic patients is dependent on accurate diagnosis as it enables the estimation of the susceptibility of the population to the infection. This demand has resulted in the development of several commercial assays employing recombinant proteins, but the results of these assays are not reliable as they do not involve comparison with natural viral antigens. We independently used the SARS-CoV-2 whole viral antigen (WVA) and recombinant nucleocapsid protein (rNP) to develop in-house ELISAs for IgG detection; the results of these ELISAs were then compared to obtain reliable results. METHODS: WVA and rNP ELISAs were performed on COVID-19 negative sera from patients before the pandemic in Brazil, and on RT-qPCR-positive or SARS-CoV-2-IgG against rNP and IgG against WVA-positive samples from recently infected patients in Sao Paulo, Brazil. RESULTS: Both ELISAs detected a large fraction of infected patients but exhibited certain drawbacks. Higher signals and lower numbers of false-negatives were observed in rNP ELISA; however, a higher fraction of false-positives was observed in control groups. A high number of false-negatives was observed with WVA ELISA. Correlating the results of rNP and WVA ELISAs resulted in improved performance for COVID-19 diagnosis. CONCLUSION: The choice of antigen is an important aspect in optimizing the laboratory diagnosis of COVID-19. The use of rNP ELISA for the detection of anti-SARS-CoV-2 IgG antibodies seems promising, but comparison of the results with those of WVA ELISA is crucial for accurate test development prior to commercialization. IgG serology using several assays, and with the spectral patterns of SARS-CoV-2, resulted in confusing information that must be clarified before the establishment of diagnostic serology criteria.

Saved in:
Bibliographic Details
Main Authors: Meireles,Luciana Regina, da Silva,Angélica Moura Freixeira, Carvalho,Camila Aparecida, Kesper,Norival, Galisteo Jr,Andrés Jimenez, Soares,Camila Pereira, Araujo,Danielle Bastos, Durigon,Edison Luiz, Oliveira,Danielle Bruna Leal, Morganti,Lígia, Chura-Chambi,Rosa Maria, de Andrade Jr,Heitor Franco
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100318
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322020000100318
record_format ojs
spelling oai:scielo:S1807-593220200001003182020-12-07Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19Meireles,Luciana Reginada Silva,Angélica Moura FreixeiraCarvalho,Camila AparecidaKesper,NorivalGalisteo Jr,Andrés JimenezSoares,Camila PereiraAraujo,Danielle BastosDurigon,Edison LuizOliveira,Danielle Bruna LealMorganti,LígiaChura-Chambi,Rosa Mariade Andrade Jr,Heitor Franco COVID-19 SARS-CoV-2 Serological Test ELISA Recombinant Nucleocapsid Protein SARS-CoV-2 Whole Viral Antigen OBJECTIVES: COVID-19 is a public health emergency of international concern whose detection in recovered asymptomatic patients is dependent on accurate diagnosis as it enables the estimation of the susceptibility of the population to the infection. This demand has resulted in the development of several commercial assays employing recombinant proteins, but the results of these assays are not reliable as they do not involve comparison with natural viral antigens. We independently used the SARS-CoV-2 whole viral antigen (WVA) and recombinant nucleocapsid protein (rNP) to develop in-house ELISAs for IgG detection; the results of these ELISAs were then compared to obtain reliable results. METHODS: WVA and rNP ELISAs were performed on COVID-19 negative sera from patients before the pandemic in Brazil, and on RT-qPCR-positive or SARS-CoV-2-IgG against rNP and IgG against WVA-positive samples from recently infected patients in Sao Paulo, Brazil. RESULTS: Both ELISAs detected a large fraction of infected patients but exhibited certain drawbacks. Higher signals and lower numbers of false-negatives were observed in rNP ELISA; however, a higher fraction of false-positives was observed in control groups. A high number of false-negatives was observed with WVA ELISA. Correlating the results of rNP and WVA ELISAs resulted in improved performance for COVID-19 diagnosis. CONCLUSION: The choice of antigen is an important aspect in optimizing the laboratory diagnosis of COVID-19. The use of rNP ELISA for the detection of anti-SARS-CoV-2 IgG antibodies seems promising, but comparison of the results with those of WVA ELISA is crucial for accurate test development prior to commercialization. IgG serology using several assays, and with the spectral patterns of SARS-CoV-2, resulted in confusing information that must be clarified before the establishment of diagnostic serology criteria.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.75 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100318en10.6061/clinics/2020/e2290
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Meireles,Luciana Regina
da Silva,Angélica Moura Freixeira
Carvalho,Camila Aparecida
Kesper,Norival
Galisteo Jr,Andrés Jimenez
Soares,Camila Pereira
Araujo,Danielle Bastos
Durigon,Edison Luiz
Oliveira,Danielle Bruna Leal
Morganti,Lígia
Chura-Chambi,Rosa Maria
de Andrade Jr,Heitor Franco
spellingShingle Meireles,Luciana Regina
da Silva,Angélica Moura Freixeira
Carvalho,Camila Aparecida
Kesper,Norival
Galisteo Jr,Andrés Jimenez
Soares,Camila Pereira
Araujo,Danielle Bastos
Durigon,Edison Luiz
Oliveira,Danielle Bruna Leal
Morganti,Lígia
Chura-Chambi,Rosa Maria
de Andrade Jr,Heitor Franco
Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
author_facet Meireles,Luciana Regina
da Silva,Angélica Moura Freixeira
Carvalho,Camila Aparecida
Kesper,Norival
Galisteo Jr,Andrés Jimenez
Soares,Camila Pereira
Araujo,Danielle Bastos
Durigon,Edison Luiz
Oliveira,Danielle Bruna Leal
Morganti,Lígia
Chura-Chambi,Rosa Maria
de Andrade Jr,Heitor Franco
author_sort Meireles,Luciana Regina
title Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
title_short Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
title_full Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
title_fullStr Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
title_full_unstemmed Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
title_sort natural versus recombinant viral antigens in sars-cov-2 serology: challenges in optimizing laboratory diagnosis of covid-19
description OBJECTIVES: COVID-19 is a public health emergency of international concern whose detection in recovered asymptomatic patients is dependent on accurate diagnosis as it enables the estimation of the susceptibility of the population to the infection. This demand has resulted in the development of several commercial assays employing recombinant proteins, but the results of these assays are not reliable as they do not involve comparison with natural viral antigens. We independently used the SARS-CoV-2 whole viral antigen (WVA) and recombinant nucleocapsid protein (rNP) to develop in-house ELISAs for IgG detection; the results of these ELISAs were then compared to obtain reliable results. METHODS: WVA and rNP ELISAs were performed on COVID-19 negative sera from patients before the pandemic in Brazil, and on RT-qPCR-positive or SARS-CoV-2-IgG against rNP and IgG against WVA-positive samples from recently infected patients in Sao Paulo, Brazil. RESULTS: Both ELISAs detected a large fraction of infected patients but exhibited certain drawbacks. Higher signals and lower numbers of false-negatives were observed in rNP ELISA; however, a higher fraction of false-positives was observed in control groups. A high number of false-negatives was observed with WVA ELISA. Correlating the results of rNP and WVA ELISAs resulted in improved performance for COVID-19 diagnosis. CONCLUSION: The choice of antigen is an important aspect in optimizing the laboratory diagnosis of COVID-19. The use of rNP ELISA for the detection of anti-SARS-CoV-2 IgG antibodies seems promising, but comparison of the results with those of WVA ELISA is crucial for accurate test development prior to commercialization. IgG serology using several assays, and with the spectral patterns of SARS-CoV-2, resulted in confusing information that must be clarified before the establishment of diagnostic serology criteria.
publisher Faculdade de Medicina / USP
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100318
work_keys_str_mv AT meireleslucianaregina naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT dasilvaangelicamourafreixeira naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT carvalhocamilaaparecida naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT kespernorival naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT galisteojrandresjimenez naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT soarescamilapereira naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT araujodaniellebastos naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT durigonedisonluiz naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT oliveiradaniellebrunaleal naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT morgantiligia naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT churachambirosamaria naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
AT deandradejrheitorfranco naturalversusrecombinantviralantigensinsarscov2serologychallengesinoptimizinglaboratorydiagnosisofcovid19
_version_ 1756432362820861952